4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000501
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Williams Gregory C. · CHIEF EXECUTIVE OFFICER
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-25 | Grant or award : show line 1 in the form Stock Options | +400,000 | 400,000 | D |
| 2020-02-25 | Grant or award : show line 2 in the form Restricted Stock Units | +200,000 | 200,000 | D |
Loading xslF345X03/form4-02262020_040214.xml…